462 related articles for article (PubMed ID: 34884872)
1. Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area.
Tulipano G
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884872
[TBL] [Abstract][Full Text] [Related]
2. Molecular action of metformin in hepatocytes: an updated insight.
Sliwinska A; Drzewoski J
Curr Diabetes Rev; 2015; 11(3):175-81. PubMed ID: 25808533
[TBL] [Abstract][Full Text] [Related]
3. Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism.
Alshawi A; Agius L
J Biol Chem; 2019 Feb; 294(8):2839-2853. PubMed ID: 30591586
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of citrus flavanones on hepatic gluconeogenesis.
Constantin RP; Constantin RP; Bracht A; Yamamoto NS; Ishii-Iwamoto EL; Constantin J
Fitoterapia; 2014 Jan; 92():148-62. PubMed ID: 24239748
[TBL] [Abstract][Full Text] [Related]
5. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
7. Cellular and Molecular Mechanisms of Metformin Action.
LaMoia TE; Shulman GI
Endocr Rev; 2021 Jan; 42(1):77-96. PubMed ID: 32897388
[TBL] [Abstract][Full Text] [Related]
8. Metformin as an Anticancer Agent.
Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
[TBL] [Abstract][Full Text] [Related]
9. Metformin: a metabolic modulator.
Pietrocola F; Kroemer G
Oncotarget; 2017 Feb; 8(6):9017-9020. PubMed ID: 28122334
[TBL] [Abstract][Full Text] [Related]
10. The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome.
Maruthini D; Harris SE; Barth JH; Balen AH; Campbell BK; Picton HM
Hum Reprod; 2014 Oct; 29(10):2302-16. PubMed ID: 25139174
[TBL] [Abstract][Full Text] [Related]
11. The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.
Thakur S; Daley B; Klubo-Gwiezdzinska J
J Mol Endocrinol; 2019 Aug; 63(2):R17-R35. PubMed ID: 31307011
[TBL] [Abstract][Full Text] [Related]
12. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.
Madiraju AK; Erion DM; Rahimi Y; Zhang XM; Braddock DT; Albright RA; Prigaro BJ; Wood JL; Bhanot S; MacDonald MJ; Jurczak MJ; Camporez JP; Lee HY; Cline GW; Samuel VT; Kibbey RG; Shulman GI
Nature; 2014 Jun; 510(7506):542-6. PubMed ID: 24847880
[TBL] [Abstract][Full Text] [Related]
13. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
Foretz M; Guigas B; Viollet B
Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
[TBL] [Abstract][Full Text] [Related]
14. Metformin: a review of its potential indications.
Wang YW; He SJ; Feng X; Cheng J; Luo YT; Tian L; Huang Q
Drug Des Devel Ther; 2017; 11():2421-2429. PubMed ID: 28860713
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo.
Madiraju AK; Qiu Y; Perry RJ; Rahimi Y; Zhang XM; Zhang D; Camporez JG; Cline GW; Butrico GM; Kemp BE; Casals G; Steinberg GR; Vatner DF; Petersen KF; Shulman GI
Nat Med; 2018 Sep; 24(9):1384-1394. PubMed ID: 30038219
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets of metformin antitumor action.
Sośnicki S; Kapral M; Węglarz L
Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
[TBL] [Abstract][Full Text] [Related]
17. Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium.
Kinaan M; Ding H; Triggle CR
Med Princ Pract; 2015; 24(5):401-15. PubMed ID: 26021280
[TBL] [Abstract][Full Text] [Related]
18. Metformin--mode of action and clinical implications for diabetes and cancer.
Pernicova I; Korbonits M
Nat Rev Endocrinol; 2014 Mar; 10(3):143-56. PubMed ID: 24393785
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in metformin action in the treatment of polycystic ovary syndrome.
Motta AB
Curr Pharm Des; 2009; 15(26):3074-7. PubMed ID: 19754381
[TBL] [Abstract][Full Text] [Related]
20. Metformin: an update.
Kirpichnikov D; McFarlane SI; Sowers JR
Ann Intern Med; 2002 Jul; 137(1):25-33. PubMed ID: 12093242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
